The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene label mismatch: CDKL5 vs undefined
  • No ClinVar Id was directly found from the curated document
  • Despite there being a valid 'cspec' property in the messages there's a discrepancy in message contents and CSPEC data: * Message Gene: CDKL5 CSPEC Genes: [ 'RS1' ] * Message MONDOs: MONDO:0010725 CSPEC MONDO: [ 'MONDO:0010725' ]
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_003159.3:c.2714-1496C>T

CA412371717

Gene: CDKL5 (HGNC:6792)
Condition: X-linked retinoschisis (MONDO:0010725)
Inheritance Mode: X-linked inheritance (recessive (HP:0001419))
UUID: 11e7f8b8-7775-4eb2-9b82-1ef928d7dd89
Approved on: 2025-05-19
Published on: 2025-05-20

HGVS expressions

NM_003159.3:c.2714-1496C>T
NC_000023.11:g.18644511C>T
CM000685.2:g.18644511C>T
NC_000023.10:g.18662631C>T
CM000685.1:g.18662631C>T
NC_000023.9:g.18572552C>T
NG_008475.1:g.223907C>T
NG_008659.3:g.37938G>A
ENST00000379984.4:c.441G>A
ENST00000379984.3:c.441G>A
ENST00000379989.6:c.2714-1496C>T
ENST00000379996.7:c.2714-1496C>T
ENST00000476595.1:n.932G>A
NM_000330.3:c.441G>A
NM_001037343.1:c.2714-1496C>T
NM_003159.2:c.2714-1496C>T
NM_000330.4:c.441G>A
NM_001037343.2:c.2714-1496C>T
More

Pathogenic

Met criteria codes 4
PS4_Supporting PP1 PVS1 PM2_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen X-linked Inherited Retinal Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RS1 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
X-linked Inherited Retinal Disease VCEP
The NM_000330.4(RS1):c.441G>A variant is a nonsense variant in amino acid 147, which results in a premature stop codon and causes a truncated protein. This variant is absent from hemizygous individuals in gnomAD v4.1.0 (PM2_Supporting). This is a nonsense variant that introduces a premature stop codon between amino acids 1-223 that is predicted to either trigger nonsense-mediated decay or to disrupt a critical C-terminal region required for proper multimerization of RS1 (PVS1, PMID: 19849666). The variant has been reported to segregate with retinal dystrophy through 1 meiosis in a family (PP1; PMID: 33851411). This variant has been reported in at least 2 apparently unrelated probands meeting the PS4 requirement of a male diagnosed with X-linked retinoschisis (PMIDs: 34645606, 33851411, PS4_Supporting). In summary, this variant is classified as pathogenic for X-linked retinoschisis based on the ClinGen X-linked Inherited Retinal Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RS1 Version 1.0.0: PM2_supporting, PVS1, PP1, and PS4_supporting (date of approval 01/24/2025).
Met criteria codes
PS4_Supporting
This variant has been reported in at least 2 apparently unrelated probands meeting the PS4 requirement of a male diagnosed with XLRS (PMIDs: 34645606, 33851411, PS4_Supporting).
PP1
The variant has been reported to segregate with retinal dystrophy through 1 meiosis in a family. (PP1; PMID: 33851411).
PVS1
This is a frameshift variant that introduces a premature stop codon between amino acids 1-223 that is predicted to either trigger nonsense-mediated decay or to disrupt a critical C-terminal region required for proper multimerization of RS1 (PVS1, PMID: 19849666).
PM2_Supporting
This variant is absent from hemizygous individuals in gnomAD v4.1.0 (PM2_Supporting).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.